Skip to content

Author

Rungnapha Yamdech

We have 1 of 22 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Effects of an optimized beta-glucan–based formulation on symptoms, functional capacity, and systemic inflammation in patients with COPD: a randomized controlled trial

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation, chronic inflammation, and oxidative stress, leading to progressive functional impairment and reduced quality of life. Beta-glucan possesses immunomodulatory and anti-inflammatory properties, but its therapeutic potenti...

Supamas Napavichayanun, Rungnapha Yamdech, Sarocha Cherdchom et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.